HSA
- Status: likely_approved
Visipaque 270 (IODIXANOL) regulatory status in Singapore.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA has authorised it.
GE HealthCare is the originator. The local marketing authorisation holder may differ — check the official source linked above.